Human Ovarian Cancer Multicellular Spheroids: A Model for Testing Antiproliferation Activity of Devilʼs Club (Oplopanax horridus) and Anticancer Agents

Abstract

This study was conducted to employ an ovarian cancer Ovcar 10 three-dimensional model to assess the antiproliferation activity of the medicinal plant Devilʼs club, Oplopanax horridus, and its active compound, alone and in combination, with chemotherapeutic agents compared to Ovcar 10 two-dimensional cells grown as monolayer cells. Ovcar 10 three-dimensional spheroids were prepared with a rotary cell culture system. Cell counting kit-8 assessed the antiproliferation activity. Apoptosis-related gene expression in three-dimensional spheroids and two- dimensional cells was analyzed with an apoptosis antibody array. Flow cytometry was used to analyze the cell cycle. Ovcar 10 cells formed compact three-dimensional spheroids after 5 days of culture in a rotary culture system. Ovcar 10 three-dimensional spheroids were significantly more resistant to killing by Devilʼs club extract, its active compound alone, gemcitabine, and paclitaxel, but not cisplatin compared to two-dimensional cells, with IC₅₀ levels closer to that observed in vivo. Devilʼs club extract and its active compound alone significantly enhanced the antiproliferation activity of cisplatin and gemcitabine at some concentrations, but did not affect the activity of paclitaxel. A number of apoptosis-related genes were differentially expressed in three-dimensional spheroids, two-dimensional cells, and cells treated with Devilʼs club extract compared to untreated controls. In three-dimensional spheroids, the proportion of cells in the G2/M phase was slightly increased and the S phase was slightly decreased compared to two-dimensional cells. Ovcar 10 cells in three-dimensional spheroids altered the expression of multiple apoptosis-related genes, which may have contributed to the increased resistance of the cells to some drugs.

Key words

Araliaceae - Oplopanax horridus - human ovarian cancer three-dimensional spheroids - North American herbal medicine - antiproliferation - anticancer agents

• References

• 1 United States Centers for Disease Control and Prevention. Available at http://www.cdc.gov/cancer/ovarian/statistics/ . Accessed May 17, 2014.
• 2 Loessner D, Stok KS, Lutolf MP, Hutmacher DW, Clements JA, Rizzi SC. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 2010; 31: 8494-8506
• 3 Schmeichel KL, Bissell MJ. Modeling tissue-specific signalling and organ function in three dimensions. J Cell Sci 2003; 116: 2377-2388
• 4 Nyga A, Cheema U, Loizidou M. 3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal 2011; 5: 239-248
• 5 Lantz TC, Swerhun K, Turner NJ. Devilsʼs Club (Oplopanax horridus): An Ethnobotanical Review. HerbalGram 2004; 62: 33-48
• 6 Tai J, Cheung S, Cheah S, Chan E, Hasman D. In vitro anti-proliferative and antioxidant studies on Devilʼs Club Oplopanax horridus . J Ethnopharmacol 2006; 108: 228-235
• 7 Tai J, Cheung S, Chan E, Hasman D. Inhibition of human ovarian cancer cell lines by Devilʼs club Oplopanax horridus . J Ethnopharmacol 2010; 127: 478-485
• 8 Sun S, Du GJ, Qi LW, Williams S, Wang CZ, Yuan CS. Hydrophobic constituents and their potential anticancer activities from Devilʼs club (Oplopanax horridus Miq.). J Ethnopharmacol 2010; 132: 280-285
• 9 Reid JM, Qu W, Safgren SL, Ames MM, Krailo MK, Seibel NL, Kuttesch J, Holcenberg J. Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors. J Clin Oncol 2004; 22: 2445-2451
• 10 Monjanel-Mouterde S, Ciccolini J, Bagarry D, Zonta-David M, Duffaud F, Favre R, Durand A. Population pharmacokinetics of cisplatin after 120-h infusion: application to routine adaptive control with feedback. J Clin Pharm Therap 2003; 28: 109-116
• 11 Ichiki M, Gohara R, Fujiki R, Hoashi S, Rikimaru T, Aizawa H. Phase I and pharmacokinetic study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer. Cancer Chemother Pharmacol 2003; 52: 67-72
• 12 Elliott NT, Yuan F. A review of three-dimensional in vitro tissue models for drug discovery and transport studies. J Pharm Sci 2011; 100: 59-74
• 13 Nirmalanandhan VS, Duren A, Hendricks P, Vielhauer G, Sittampalam GS. Activity of anticancer agents in a three-dimensional cell culture model. Assay Drug Dev Tech 2010; 8: 581-590
• 14 Kumar HR, Zhong X, Hoelz DJ, Rescorla FJ, Hickey RJ, Malkas LH, Sandoval JA. Three-dimensional neuroblastoma cell culture: proteomic analysis between monolayer and multicellular tumor spheroids. Pediatr Surg Int 2008; 24: 1229-1234
• 15 Yamada KM, Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007; 24: 601-610
• 16 Sutherland RM. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 1988; 240: 177-184
• 17 Ingram M, Techy GB, Saroufeem R, Yazan O, Narayan KS, Goodwin TJ, Spaulding GF. Three-dimensional growth patterns of human tumor cell line in simulated microgravity of a NASA bioreactor. In Vitro Cell Biol Anim 1997; 33: 459-466
• 18 Kunz-Schughart LA, Freyer JP, Hofstaedter F, Ebner R. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen 2004; 9: 273-285
• 19 Timmins NE, Dietmair S, Nielsen LK. Hanging-drop multicellular spheroids as a model of tumour angiogenesis. Angiogenesis 2004; 7: 97-103
• 20 Kobaisy M, Abramowski Z, Lermer L, Saxena G, Hancock RE, Towers GH, Doxsee D, Stokes RW. Antimycobacterial polyynes of Devilʼs club (Oplopanax horridus), a North American native medicinal plant. J Nat Prod 1997; 60: 1210-1213
• 21 Tai J, Cheung SS, Ou D, Warnock GL, Hasman D. Antiproliferation activity of Devilʼs club (Oplopanax horridus) and anticancer agents on human pancreatic cancer multicellular spheroids. Phytomedicine 2014; 21: 506-514
• 22 Wang CZ, Zhang Z, Huang WH, Du DJ, Wen XD, Calway T, Yu C, Nass R, Zhao J, Du W, Li SP, Yuan CS. Identification of potential anticancer compounds from Oplopanax horridus . Phytomedicine 2013; 20: 999-1006
• 23 Yang Z, Zhao X. A 3D model of ovarian cancer cell lines on peptide nanofiber scaffold to explore the cell-scaffold interaction and chemotherapeutic resistance of anticancer drugs. Int J Nanomedicine 2011; 6: 303-310
• 24 Horning JL, Sahoo SK, Vijayaraghavalu S, Dimitrijevic S, Vasir JK, Jain TK, Pand AK, Labhasetwar V. 3-D tumor model for in vitro evaluation of anticancer drugs. Mol Pharm 2008; 5: 849-862
• 25 LaRue KEA, Khalil M, Freyer JP. Microenvironmental regulation of proliferation in multicellular spheroids is mediated through differential expression of cyclin-dependent kinase inhibitors. Cancer Res 2004; 64: 1621-1631
• 26 Walker J, Martin C, Callaghan R. Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy. Eur J Cancer 2004; 40: 594-605
• 27 Smalley KS, Lioni M, Herlyn M. Life isnʼt flat: taking cancer biology to the next dimension. In Vitro Cell Dev Biol Anim 2006; 42: 242-247
• 28 Nelson CM, Bissel MJ. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol 2005; 15: 342-352
• 29 Zietarska M, Maugard CM, Filali-Mouhim A, Alam-Fahmy M, Tonin PN, Provencher DM, Mes-Masson AM. Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC). Mol Carcinogenesis 2007; 46: 872-885
• 30 Zurawa-Janicka D, Skorko-Glonek J, Lipinska B. HtrA proteins as targets in therapy of cancer and other diseases. Expert Opin Ther Targets 2010; 14: 665-679
• 31 Kongpetch S, Kukongviriyapen V, Prawan A, Senggunprai L, Kukongviriyapan U, Buranrat B. Crucial role of heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to chemotherapeutic agents. PLoS One 2012; 7: e34994
• 32 Hassan MK, Watari H, Han Y, Mitamura T, Hosaka M, Wang L, Tanaka S, Sakuragi N. Clusterin is a potential molecular predictor for ovarian cancer patientʼs survival: targeting clusterin improves response to paclitaxel. J Exp Clin Cancer Res 2011; 30: 113
• 33 Glorieux C, Dejeans N, Sid B, Beck R, Calderon PB, Verrax J. Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy. Biochem Pharmacol 2011; 82: 1384-1390
• 34 Yang D, Torres CM, Bardhan K, Zimmerman M, McGaha TL, Liu K. Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo . J Immunol 2012; 188: 4441-4449
• 35 Cui J, Nan KJ, Tian T, Guo YH, Zhao N, Wang L. Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture. World J Gastroenterol 2007; 13: 5432-5439
• 36 Mueller-Klieser W, Schreiber-Klais S, Walenta S, Kreuter MH. Bioactivity of well-defined green tea extracts in multicellular tumor spheroids. Int J Oncol 2002; 21: 1307-1315
• 37 Kueng W, Silber E, Eppenberger U. Quantification of cells cultured on 96-well plates. Anal Biochem 1989; 182: 16-19
• 38 Berenbaum MC. What is synergy?. Pharmacol Rev 1989; 41: 93-141
• 39 Wagner H, Ulrich-Merzenich G. Synergy research: approaching a new generation of phytochemicals. Phytomedicine 2009; 16: 97-110